FACE Related Analyst Comments
-
Citi Maintains 'Buy' Rating on Physicians Formula (FACE), Lowers PT and 2008-09 Estimates
-
Piper Jaffray Maintains 'Buy' Rating on Physicians Formula Holdings (FACE), But Lowers PT and Estimates
-
Citi's Analysts Announce Favorite Strategy Stocks After Small/Mid Cap Conference
-
Piper Jaffray Reiterates Buy on Physicians Formula (FACE); $16 PT
-
Piper Jaffray Lowers Their Price Target on Physicians Formula (FACE) to $15
-
Piper Jaffray Defends Physicians Formula (FACE) Following Warning
Back to FACE Stock Lookup
